The Cabinet of Ministers approved a bill on updating the strategy, which provides for the restoration of war-damaged territories and the integration of EU requirements.
The Kyiv Commercial Court will hear a lawsuit on 16 November seeking to invalidate an investment agreement for the Main Astronomical Observatory site. The investor is LLC "Freds Resorts", whose shares are held by Vladislava Molchanova's sons.
Ukrainian President explained why a new head of the Office of the Prosecutor General has not yet been appointed and responded to accusations made against him by the former head of the department.
Desnyansky District Court is hearing the prosecution's case against Vasyl Bilohura. He is accused of inflating construction material costs during the reconstruction of a gymnasium funded by Swiss grants.
Analytics show that 1,399 documents submitted by 1,012 individuals working for the SBU are hidden from public access. The record is for 2023.
The new Deputy Minister of Digital Transformation, Valeriia Koval, holds a degree in political science and has extensive experience in the digitalisation sector.
Anna Prokop described how two men and a woman surrounded a young Ukrainian in a Żabka store, insulting him and threatening to return after his shift.
A company uniting marine drone experts and investors has appeared in Bucha. Analysis of the ownership structure revealed links to the "Falkor" fund and a discussion regarding the identity of one of the beneficiaries.
A team of researchers from Weill Cornell Medicine has made a stunning discovery that could radically change approaches to the treatment of type 1 diabetes. The new method developed by the scientists promises to significantly improve the quality of life for millions of patients worldwide.
How does the new method work?
The new approach involves transplanting not only insulin-producing cells but also cells that form blood vessels. This combination allows for improved survival of the transplanted cells, which is a significant step in the fight against type 1 diabetes.
Key advantages of the new method:
Simplified procedure: Cell transplantation is now performed under the skin, rather than in the liver, as was the case with previous methods. This significantly simplifies the process and makes it less invasive.
Results in animals: Experiments conducted on laboratory animals showed remarkable results — blood sugar levels stabilised and remained within normal limits for more than 20 weeks.
Minimal rejection: The new method significantly reduces the risk of rejection of the transplanted cells, thereby increasing its effectiveness.
Comments
No comments yet. Be the first!